Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice

被引:0
作者
Gong, Mengjuan [1 ]
Lu, Hailong [1 ]
Li, Lixi [1 ]
Feng, Meiqi [1 ]
Zou, Zhongjie [1 ]
机构
[1] Guangdong Pharmaceut Univ, Sch Chinese Mat Med, Guangzhou 510006, Peoples R China
关键词
METABOLISM; URIDINE; ACIDS;
D O I
10.1039/d2fo03054c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic steatohepatitis (NASH) is a chronic liver disease with few therapeutic options available currently. Hemp seed oil extracted from the seeds of hemp (Cannabis sativa L.) has significant nutritional and biological properties due to the unique composition of polyunsaturated fatty acids and various antioxidant compounds. However, little is known about the beneficial effects and molecular mechanisms of hemp seed oil on NASH. Here, the hepatoprotective effects of hemp seed oil on methionine-choline-deficient (MCD) diet-induced NASH in C57BL/6 mice were explored via integration of transcriptomics and metabolomics. Hemp seed oil could improve hepatic steatosis, inflammation and fibrosis in mice with MCD diet-induced NASH. In a nuclear magnetic resonance (NMR)-based metabonomic study, the hepatic and urinary metabolic profiles of mice supplemented with hemp seed oil showed a tendency to recover to healthy controls compared to those of NASH mice. Eight potential biomarkers associated with NASH in both liver tissue and urine were restored to near normal levels by administration of hemp seed oil. The proposed pathways were mainly involved in pyrimidine metabolism, one-carbon metabolism, amino acid metabolism, glycolysis and the tricarboxylic acid (TCA) cycle. Hepatic transcriptomics based on Illumina RNA-Seq sequencing showed that hemp seed oil exerted anti-NASH activities by regulating multiple signaling pathways, e.g., downregulation of the TNF signaling pathway, the IL-17 signaling pathway, the MAPK signaling pathway and the NF-kappa B signaling pathway, which played a pivotal role in the pathogenesis of NASH. In particular, integration of metabonomic and transcriptomic results suggested that hemp seed oil could attenuate NASH-related liver fibrosis by inhibition of glutaminolysis. These results provided new insights into the hepatoprotective effects of hemp seed oil against MCD diet-induced NASH and hemp seed oil might have potential as an effective therapy for NASH.
引用
收藏
页码:2096 / 2111
页数:16
相关论文
共 35 条
  • [1] The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review
    Abe, Rose Anne M.
    Masroor, Anum
    Khorochkov, Arseni
    Prieto, Jose
    Singh, Karan B.
    Nnadozie, Maduka C.
    Abdal, Muhammad
    Shrestha, Niki
    Mohammed, Lubna
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [2] Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis
    Cabre, Noemi
    Luciano-Mateo, Fedra
    Baiges-Gaya, Gerard
    Fernandez-Arroyo, Salvador
    Rodriguez-Tomas, Elisabet
    Hernandez-Aguilera, Anna
    Paris, Marta
    Sabench, Fatima
    Del Castillo, Daniel
    Lopez-Miranda, Jose
    Menendez, Javier A.
    Camps, Jordi
    Joven, Jorge
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (03) : 374 - 387
  • [3] One-Carbon Metabolism in Fatty Liver Disease and Fibrosis: One-Carbon to Rule Them All
    da Silva, Robin P.
    Eudy, Brandon J.
    Deminice, Rafael
    [J]. JOURNAL OF NUTRITION, 2020, 150 (05) : 994 - 1003
  • [4] Betaine chemistry, roles, and potential use in liver disease
    Day, Christopher R.
    Kempson, Stephen A.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (06): : 1098 - 1106
  • [5] Systems Biological Responses to Chronic Perfluorododecanoic Acid Exposure by Integrated Metabonomic and Transcriptomic Studies
    Ding, Lina
    Hao, Fuhua
    Shi, Zhimin
    Wang, Yulan
    Zhang, Hongxia
    Tang, Huiru
    Dai, Jiayin
    [J]. JOURNAL OF PROTEOME RESEARCH, 2009, 8 (06) : 2882 - 2891
  • [6] Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
    Du, Kuo
    Chitneni, Satish K.
    Suzuki, Ayako
    Wang, Ying
    Henao, Ricardo
    Hyun, Jeongeun
    Premont, Richard T.
    Naggie, Susanna
    Moylan, Cynthia A.
    Bashir, Mustafa R.
    Abdelmalek, Manal F.
    Diehl, Anna Mae
    [J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2020, 10 (01): : 1 - 21
  • [7] Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells
    Du, Kuo
    Hyun, Jeongeun
    Premont, Richard T.
    Choi, Steve S.
    Michelotti, Gregory A.
    Swiderska-Syn, Marzena
    Dalton, George D.
    Thelen, Eric
    Rizi, Bahar Salimian
    Jung, Youngmi
    Diehl, Anna Mae
    [J]. GASTROENTEROLOGY, 2018, 154 (05) : 1465 - +
  • [8] The Seed of Industrial Hemp (Cannabis sativaL.): Nutritional Quality and Potential Functionality for Human Health and Nutrition
    Farinon, Barbara
    Molinari, Romina
    Costantini, Lara
    Merendino, Nicolo
    [J]. NUTRIENTS, 2020, 12 (07) : 1 - 60
  • [9] Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver
    Feng, Yanan
    Sun, Wenxiu
    Sun, Fengcui
    Yin, Guoliang
    Liang, Pengpeng
    Chen, Suwen
    Liu, Xiangyi
    Jiang, Tongfei
    Zhang, Fengxia
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 3829 - 3845
  • [10] Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors
    Gehrke, Nadine
    Woerns, Marcus A.
    Huber, Yvonne
    Hess, Moritz
    Straub, Beate K.
    Hoevelmeyer, Nadine
    Waisman, Ari
    Kim, Yong Ook
    Schuppan, Detlef
    Galle, Peter R.
    Schattenberg, Joern M.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (06) : 1188 - 1197